Product Information
TELMISARTAN 20 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1070 per EA under NDC 68462019930. Its NADAC has been published 272 times since Apr 14, 2021.
Strength
20 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462019930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090032On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 20 MG TABLET has been published 272 times since Apr 14, 2021, and over the history we have for it it has declined 76.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1070 per EA |
|---|---|
| All-time high | $0.4810 (Jul 14, 2021) |
| All-time low | $0.1044 (Mar 18, 2026) |
| 52-week high | $0.1174 |
| 52-week low | $0.1044 |
| Median price | $0.1853 |
| Average price | $0.2034 |
| Largest weekly change | +34.5% (Aug 21, 2024) |
| Weeks tracked | 272 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 20 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1070 per EA (NDC 68462019930), effective Jun 24, 2026.
How has the price of TELMISARTAN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 20 MG TABLET has declined 76.3%. It has been tracked across 272 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 20 MG TABLET?
Since Apr 14, 2021, the NADAC for TELMISARTAN 20 MG TABLET has ranged from a low of $0.1044 (Mar 18, 2026) to a high of $0.4810 (Jul 14, 2021), with a median of $0.1853 per EA.
Are there cheaper alternatives to TELMISARTAN 20 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN 20 MG TABLET, but none are currently priced below it.
Who manufactures TELMISARTAN 20 MG TABLET?
TELMISARTAN 20 MG TABLET (NDC 68462019930) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification